Eye drop formulations face challenges of rapid clearance from the corneal surface, hindering effective drug delivery to treat ocular diseases.
The invention introduces an ocular drug delivery device to overcome rapid clearance and facilitate effective drug penetration into the corneal epithelium.
Developing an ocular drug delivery device with a microprojection array on a concave surface, offering improved drug penetration into the corneal epithelium.
Potential Indian Clients: Pharmaceutical companies focusing on ophthalmic treatments, hospitals, eye clinics, and research institutions in India.
Current TRL: NA
Funded by: NA
IPC: A61K
Domain: Healthcare/Pharmaceuticals
This website uses cookies or similar technologies, to enhance your browsing experience.